OR WAIT null SECS
June 03, 2025
Article
This FDA News Month in Review provides a round-up of regulatory decisions from May 2025.
May 02, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from April 2025.
March 31, 2025
This FDA News Month in Review provides a round-up of regulatory decisions from March 2025.
March 04, 2025
The biosimilars are expected to become available in the US in June 2025.
January 14, 2025
Recommendations have been largely preserved since 2018 and the USPSTF acknowledged the need for more research and better risk assessment tools.
December 03, 2024
CT-P41 had similar rates of bone mineral density increases and adverse events in data presented at the ACR 2024 Convergence.
October 04, 2024
September 10, 2024
Fragility fractures occur every minute in France, totaling 500,000 annually. A report calls for expanding fracture liaison services to address the growing osteoporosis burden.
August 15, 2024
Both treatment arms experienced significant improvements in measured parameters from baseline, although these were not all statistically significant.
July 17, 2024
The mean percentage change from baseline in lumbar spine bone mineral density was comparable between treatment groups at 18 months.
